26/10/2026 02:05
EQS-News: Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Ailytics / Key words: Private Equity/Financing br/ Tin Men Capital leads US$7.4M Series A for Vision AI startup Ailytics to expand across APAC, US and Gulf... Lire...
25/10/2026 23:55
Artprice by Artmarket: Defending Authors' Creative Freedom with AI
pstrongAs the fall 2026 literary season unfolds, daily pronouncements on AI are coming at a relentless pace from the publishing world and literary prize organizations: rejection of AIgenerated writing, tolerance of AI assistance with research, disclosure requirements, or recognition of creative... Lire...
24/10/2026 23:44
EQS-Adhoc: HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: HomeToGo SE / Key words: Otherbr/ HomeToGo SE: Unauthorized data exfiltration at subsidiary SECRA Bookings GmbH br/br/ 24Oct2026 / 23:44 CET/CESTbr/ Disclosure of an inside information acc.... Lire...
24/10/2026 15:15
Artmarket.com : Artprice and its CEO, thierry Ehrmann, congratulate Brognon Rollin, winners of the 2026 Marcel Duchamp Prize.
pemThought and Human Experience at the Heart of Creation/em/p pPress Release October 23, 2026/p pstrongA loyal, longtime partner of the Marcel Duchamp Prize, Artprice by Artmarket congratulates the duo Brognon Rollin, whose award was announced on Thursday, October 22, 2026, by Claude Bonnin,... Lire...
24/10/2026 14:15
China Cosmetics Review : Winners of the 2026 INPD Awards Announced, C-Beauty Takes Home Multiple Prestigious Honors
html xmlns=http://www.w3.org/1999/xhtmlbodytable border= cellpadding= cellspacing=trtd p br/ EQS Newswire / span24/10/2026 / 14:15 CET/CEST/spanbr//p divpPARIS, FRANCE – a... Lire...
24/10/2026 13:00
NANOBIOTIX : NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma
PRESS RELEASE NANOBIOTIX ANNOUNCES FINAL DATA FROM PHASE 1 STUDY EVALUATING JNJ1900 NBTXR3 WITH IMMUNE CHECKPOINT INHIBITORS AS A 2L THERAPY IN ANTIPD1RESISTANT PRIMARY CUTANEOUS MELANOMA • In 24 heavily pretreated patients with... Lire...
24/10/2026 06:30
Thailand Board of Investment (BOI) : AI and EV Boom Draws $690 Million in Advanced Materials Investment Plans to Thailand
html xmlns=http://www.w3.org/1999/xhtmlbodytable border= cellpadding= cellspacing=trtd p br/ EQS Newswire / span24/10/2026 / 06:30 CET/CEST/spanbr//p div pBANGKOK, THAILAND a... Lire...
24/10/2026 00:25
Caldwell Partners International, Inc. : Caldwell Announces Sale of IQTalent
pstrong id=datelineTORONTO, ON / a href=https://www.accessnewswire.com/ACCESS Newswire/a / October 23, 2026 / /strongCaldwell TSX:CWLOTCQX:CWLPF, a leading retained executive search firm, today announced it has completed the sale of substantially all of the net operating assets of its wholly owned... Lire...
24/10/2026 00:04
Sparta Group : Sparta Capital Ltd. Provides Corporate Update on Reinstatement Review, Financial Statement Corrections and Governance Matters
pstrong id=datelineTORONTO, ON / a href=https://www.accessnewswire.com/ACCESS Newswire/a / October 23, 2026 / /strongSparta Group TSXV:SAY the "Corporation", the "Company", "Sparta Group", "Sparta Capital", "SAY.V" or "Sparta" reports on... Lire...